Debashish Mishra

Debashish Mishra

Auto-generated profile, based on publicly available information

Debashish Mishra

Institute of Medical Sciences and Sum Hospital Bhubaneswar India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
NANupoor Acharya
Nupoor Acharya
SSShefali Khanna Sharma
Shefali Khanna Sharma
DMDebashish Mishra
Debashish Mishra
SDSahajal Dhooria
Sahajal Dhooria
VDVarun Dhir
Varun Dhir
SJSanjay K. Jain
Sanjay K. Jain

2 August 2020 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
SJSiddharth Jain
Siddharth Jain
DMDebashish Mishra
Debashish Mishra
VDVarun Dhir
Varun Dhir

24 August 2020 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
DMDebashish Mishra
Debashish Mishra
SSShefali K Sharma
Shefali K Sharma

1 July 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
DMDebashish Mishra
Debashish Mishra
ACArghya Chattopadhyay
Arghya Chattopadhyay
SJSanjay K. Jain
Sanjay K. Jain
VDVarun Dhir
Varun Dhir
We read with great interest the article on ‘Gradual tapering TNF inhibitors vs conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study’1by van Mulligen et al . This was the first head-to-head comparison between two tapering strategies—biological versus conventional in rheumatoid arthritis. The final results favour tapering tumour necrosis factor inhibitors (TNFis) before conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). However, certain points need clarifications. First, many patients in the …